These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8594861)

  • 41. Thrombotic microangiopathy in adult Still's disease.
    Quéméneur T; Noel LH; Kyndt X; Droz D; Fleury D; Binaut R; Lemaitre V; Gobert P; Vanhille P
    Scand J Rheumatol; 2005; 34(5):399-403. PubMed ID: 16234190
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experience.
    Vo AA; Cam V; Toyoda M; Puliyanda DP; Lukovsky M; Bunnapradist S; Peng A; Yang K; Jordan SC
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):844-52. PubMed ID: 17699296
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intravenous immune globulin in neuromuscular disorders.
    Gupta S
    West J Med; 1997 Nov; 167(5):349-50. PubMed ID: 9392991
    [No Abstract]   [Full Text] [Related]  

  • 44. Compartment syndrome, rhabdomyolysis and risk of acute renal failure as complications of the lithotomy position.
    Bocca G; van Moorselaar JA; Feitz WF; van der Staak FH; Monnens LA
    J Nephrol; 2002; 15(2):183-5. PubMed ID: 12018636
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Post-transplantation renal impairment and intravenous immunoglobulin.
    Harden PN; Robertson S; Isles CG; Rodger RS
    Nephrol Dial Transplant; 1996 Sep; 11(9):1896. PubMed ID: 8918656
    [No Abstract]   [Full Text] [Related]  

  • 46. Contrast-induced nephrotoxicity in renal allograft recipients.
    Ahuja TS; Niaz N; Agraharkar M
    Clin Nephrol; 2000 Jul; 54(1):11-4. PubMed ID: 10939751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aseptic meningitis and abducens nerve palsy as a serious side effect of high dose intravenous immunoglobulin used in a patient with renal transplantation.
    Wright SE; Shaikh ZH; Castillo-Lugo JA; Tanriover B
    Transpl Infect Dis; 2008 Jul; 10(4):294-7. PubMed ID: 18086279
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis C and immune globulin.
    Prince AM; Horowitz B
    N Engl J Med; 1995 May; 332(18):1236; author reply 1236-7. PubMed ID: 7700325
    [No Abstract]   [Full Text] [Related]  

  • 49. The use of intravenous immune globulin to reduce panel reactive antibodies in children with end stage renal disease.
    Moore C
    Nephrol Nurs J; 2002 Jun; 29(3):303, 302. PubMed ID: 12164083
    [No Abstract]   [Full Text] [Related]  

  • 50. Multiorgan failure induced by intravenous immunoglobulin.
    Ikeda M; Hamasaki Y; Hataya H; Honda M; Sugai K
    Acta Paediatr; 2000 Nov; 89(11):1393. PubMed ID: 11106058
    [No Abstract]   [Full Text] [Related]  

  • 51. Acute renal failure after intravenous immunoglobulin therapy.
    Emilie S; Dougados M; Nguyen M; Gossec L
    Clin Exp Rheumatol; 2010; 28(3):444. PubMed ID: 20576233
    [No Abstract]   [Full Text] [Related]  

  • 52. [Acute kidney failure following intravenous administration of high doses of immunoglobulins].
    Cabre P; Smadja D; Odry L; Donikian JC; Vernant JC
    Presse Med; 1994 Jan; 23(3):142. PubMed ID: 8177854
    [No Abstract]   [Full Text] [Related]  

  • 53. Important drug information: immune globulin intravenous (human).
    Epstein JS; Gaines A; Kapit R; Pierce R; Potter R; Varricchio F
    Int J Trauma Nurs; 1999; 5(4):139-40. PubMed ID: 10661146
    [No Abstract]   [Full Text] [Related]  

  • 54. Acute renal failure and myocarditis associated with intravenous immunoglobulin therapy.
    Akhtar I; Bastani B
    Ann Intern Med; 2003 Aug; 139(4):W65. PubMed ID: 12966002
    [No Abstract]   [Full Text] [Related]  

  • 55. High-dose intravenous IgG treatment and acute renal failure.
    Veber B; Mohammedi I; Gachot B; Bédos JP; Wolff M
    Intensive Care Med; 1995 Mar; 21(3):288-9. PubMed ID: 7790625
    [No Abstract]   [Full Text] [Related]  

  • 56. Acute renal failure associated with immunoglobulin administration.
    Michail S; Nakopoulou L; Stavrianopoulos I; Stamatiadis D; Avdikou K; Vaiopoulos G; Stathakis C
    Nephrol Dial Transplant; 1997 Jul; 12(7):1497-9. PubMed ID: 9249797
    [No Abstract]   [Full Text] [Related]  

  • 57. Association of immune globulin intravenous and thromboembolic adverse events.
    Ovanesov MV; Menis MD; Scott DE; Forshee R; Anderson S; Bryan W; Golding B
    Am J Hematol; 2017 Apr; 92(4):E44-E45. PubMed ID: 28066925
    [No Abstract]   [Full Text] [Related]  

  • 58. Renal toxicity of intravenous immunoglobulin.
    Stewart RR; Winney RJ; Cash JD
    Vox Sang; 1993; 65(3):244. PubMed ID: 8249370
    [No Abstract]   [Full Text] [Related]  

  • 59. Eczematous reactions to human immune globulin.
    Whittam LR; Hay RJ; Hughes RA
    Br J Dermatol; 1997 Sep; 137(3):481-2. PubMed ID: 9349364
    [No Abstract]   [Full Text] [Related]  

  • 60. Administering immune globulin.
    Rosenthal K
    Nursing; 2006 Mar; 36(3):20-1. PubMed ID: 16523070
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.